What is it about?
From a web-based survey, we collected data from French and Spanish people with multiple sclerosis (n=641). We found similar percentages of cannabis-based products users among both sub-populations (~20%). Such users were more likely to suffer from greater disability and pain than non-users. Herb/resin was the most commonly used product.
Photo by Christina Winter on Unsplash
Why is it important?
Our findings show that multiple sclerosis patients the most in need of relief are likely to use cannabis-based products to alleviate their symptoms, especially herb/resin, regardless of the local legislation.
Read the Original
This page is a summary of: Symptom severity is a major determinant of cannabis‐based products use among people with multiple sclerosis, Journal of Clinical Nursing, March 2023, Wiley, DOI: 10.1111/jocn.16674.
You can read the full text:
The following have contributed to this page